Nipah virus resurfaces in Kerala, Pg1

Context:

• Kerala has reported two fresh Nipah virus cases, triggering health alerts and containment measures across three districts. The resurgence follows a previous confirmed case from May 2025.

Key Highlights:

• A woman in Kozhikode died of Acute Encephalitis Syndrome (AES); her post-mortem confirmed Nipah virus infection.
• A total of 345 people have been put on the Nipah contact list in Kerala.
• Containment zones have been declared in Palakkad and Malappuram districts.
• The Health Department initiated control measures even before official confirmation.
• 26 coordination committees have been formed across affected districts to manage the situation.
• Police assistance has been sought for contact tracing and quarantine enforcement.
• People in containment zones are mandated to wear masks in public places.
• Experts have warned against disturbing roosting bats, a natural reservoir of the virus.
• Surveillance is being intensified around hospitals and any unexplained pneumonia or AES deaths.

Critical Issues Raised:

• Persistent vulnerability in Nipah-prone districts.
• Healthcare workers remain at high risk due to late confirmation.
• Community unawareness about bat-human transmission links.
• Gaps in real-time surveillance and early warning mechanisms.
• Risk of inter-district spread due to patient mobility.

Way Forward:

• Establish permanent NiV surveillance cells in endemic zones.
• Strengthen One Health framework—linking veterinary, environmental, and human health responses.
• Public sensitisation on bat avoidance, hygiene, and early symptom reporting.
• State-wise protocol manuals for zoonotic outbreak readiness.
• Research investment in diagnostics and preventive therapeutics (monoclonal antibodies, vaccines).
• Regular drills for rapid response teams, similar to cyclone preparedness protocols.

Scientific Concepts Involved:

1. Nipah Virus (NiV):

• Zoonotic virus from Paramyxoviridae, first identified in Malaysia (1998).
• Reservoir: Fruit bats (Pteropus spp).
• Transmission: Human-to-human, animal-to-human (especially pigs, bats), contaminated fruits or surfaces.
• Symptoms: Fever, headache, vomiting, encephalitis; mortality rate: 40–75%.
• No vaccine or specific antiviral; treatment is symptomatic and supportive.

2. Acute Encephalitis Syndrome (AES): A clinical term for rapid-onset fever and neurological symptoms, often linked to viral infections.